Literature DB >> 25392278

Role of tumor necrosis factor-α and interleukin-1β in anorexia induction following oral exposure to the trichothecene deoxynivalenol (vomitoxin) in the mouse.

Wenda Wu1, Haibin Zhang.   

Abstract

The trichothecene deoxynivalenol (DON), a foodborne mycotoxin found in grain-based foods, has been associated with human and animal food poisoning. Although induction of anorexia has been described as a hallmark of DON-induced toxicity in many animal species, the mechanistic basis for this adverse effect is not fully understood. The purpose of this research was to determine the role of two proinflammatory cytokines, tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in DON-induced anorexia. In a nocturnal mouse food consumption model, DON-induced anorectic response occurred at 1 hr and lasted up to 6 hr. Similar anorectic effects were observed following acute administration of exogenous TNF-α and IL-1β. Oral exposure to DON at 5 mg/kg bw stimulated splenic and hepatic mRNA and plasma protein elevations of TNF-α and IL-1β that corresponded to anorexia induction. Pretreatment with the TNF-α receptor (TNFR) antagonist R-7050 dose-dependently attenuated both TNF-α- and DON-induced anorexia. While, the type 1 IL-1 receptor (IL-1R1) antagonist IL-1RA dose-dependently attenuated both IL-1β- and DON-induced anorexia. Taken together, the results suggest that both TNF-α and IL-1β play contributory role in anorexia induction following oral exposure to DON.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25392278     DOI: 10.2131/jts.39.875

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  8 in total

Review 1.  Inflammation and nutrition in children with chronic kidney disease.

Authors:  Juan Tu; Wai W Cheung; Robert H Mak
Journal:  World J Nephrol       Date:  2016-05-06

2.  Hyperoxaluria Requires TNF Receptors to Initiate Crystal Adhesion and Kidney Stone Disease.

Authors:  Shrikant R Mulay; Jonathan N Eberhard; Jyaysi Desai; Julian A Marschner; Santhosh V R Kumar; Marc Weidenbusch; Melissa Grigorescu; Maciej Lech; Nuru Eltrich; Lisa Müller; Wolfgang Hans; Martin Hrabě de Angelis; Volker Vielhauer; Bernd Hoppe; John Asplin; Nicolai Burzlaff; Martin Herrmann; Andrew Evan; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2016-09-09       Impact factor: 10.121

3.  A bed nucleus of stria terminalis microcircuit regulating inflammation-associated modulation of feeding.

Authors:  Yong Wang; JungMin Kim; Matthew B Schmit; Tiffany S Cho; Caohui Fang; Haijiang Cai
Journal:  Nat Commun       Date:  2019-06-24       Impact factor: 14.919

4.  Combined Effect of Deoxynivalenol (DON) and Porcine Circovirus Type 2 (Pcv2) on Inflammatory Cytokine mRNA Expression.

Authors:  Chao Gu; Xiuge Gao; Dawei Guo; Jiacai Wang; Qinghua Wu; Eugenie Nepovimova; Wenda Wu; Kamil Kuca
Journal:  Toxins (Basel)       Date:  2021-06-13       Impact factor: 4.546

5.  Tumor necrosis factor-alpha is associated with mineral bone disorder and growth impairment in children with chronic kidney disease.

Authors:  Kelly Meza; Sharmi Biswas; Yuan-Shan Zhu; Anuradha Gajjar; Eduardo Perelstein; Juhi Kumar; Oleh Akchurin
Journal:  Pediatr Nephrol       Date:  2021-01-02       Impact factor: 3.651

6.  High Sensitivity of Aged Mice to Deoxynivalenol (Vomitoxin)-Induced Anorexia Corresponds to Elevated Proinflammatory Cytokine and Satiety Hormone Responses.

Authors:  Erica S Clark; Brenna M Flannery; Elizabeth M Gardner; James J Pestka
Journal:  Toxins (Basel)       Date:  2015-10-19       Impact factor: 4.546

7.  Comparison of Anorectic Potencies of Type A Trichothecenes T-2 Toxin, HT-2 Toxin, Diacetoxyscirpenol, and Neosolaniol.

Authors:  Jie Zhang; Hua Zhang; Shengli Liu; Wenda Wu; Haibin Zhang
Journal:  Toxins (Basel)       Date:  2018-04-29       Impact factor: 4.546

8.  Deoxynivalenol Induces Inflammation in IPEC-J2 Cells by Activating P38 Mapk And Erk1/2.

Authors:  Hua Zhang; Xiwen Deng; Chuang Zhou; Wenda Wu; Haibin Zhang
Journal:  Toxins (Basel)       Date:  2020-03-13       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.